DYNAVAX TECHNOLOGIES CORP (DVAX) Fundamental Analysis & Valuation

NASDAQ:DVAX • US2681582019

Current stock price

15.5 USD
0 (0%)
At close:
15.5 USD
0 (0%)
After Hours:

This DVAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. DVAX Profitability Analysis

1.1 Basic Checks

  • In the past year DVAX was profitable.
  • In the past year DVAX had a positive cash flow from operations.
  • In multiple years DVAX reported negative net income over the last 5 years.
  • DVAX had a positive operating cash flow in 4 of the past 5 years.
DVAX Yearly Net Income VS EBIT VS OCF VS FCFDVAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

  • DVAX has a Return On Assets of -4.59%. This is amongst the best in the industry. DVAX outperforms 86.40% of its industry peers.
  • DVAX's Return On Equity of -8.13% is amongst the best of the industry. DVAX outperforms 88.70% of its industry peers.
  • DVAX's Return On Invested Capital of 1.05% is amongst the best of the industry. DVAX outperforms 89.08% of its industry peers.
Industry RankSector Rank
ROA -4.59%
ROE -8.13%
ROIC 1.05%
ROA(3y)10.61%
ROA(5y)3.5%
ROE(3y)17.99%
ROE(5y)-8.35%
ROIC(3y)N/A
ROIC(5y)N/A
DVAX Yearly ROA, ROE, ROICDVAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • DVAX's Profit Margin has declined in the last couple of years.
  • The Operating Margin of DVAX (3.16%) is better than 89.46% of its industry peers.
  • With an excellent Gross Margin value of 83.17%, DVAX belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
  • DVAX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.16%
PM (TTM) N/A
GM 83.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-15.64%
PM growth 5YN/A
GM growth 3Y10.73%
GM growth 5Y12.85%
DVAX Yearly Profit, Operating, Gross MarginsDVAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DVAX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DVAX is destroying value.
  • DVAX has less shares outstanding than it did 1 year ago.
  • DVAX has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DVAX has a worse debt to assets ratio.
DVAX Yearly Shares OutstandingDVAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DVAX Yearly Total Debt VS Total AssetsDVAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • DVAX has an Altman-Z score of 2.44. This is not the best score and indicates that DVAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • DVAX's Altman-Z score of 2.44 is fine compared to the rest of the industry. DVAX outperforms 67.24% of its industry peers.
  • DVAX has a debt to FCF ratio of 3.24. This is a good value and a sign of high solvency as DVAX would need 3.24 years to pay back of all of its debts.
  • The Debt to FCF ratio of DVAX (3.24) is better than 92.34% of its industry peers.
  • DVAX has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.49, DVAX is not doing good in the industry: 69.73% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.24
Altman-Z 2.44
ROIC/WACC0.13
WACC8.24%
DVAX Yearly LT Debt VS Equity VS FCFDVAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 7.62 indicates that DVAX has no problem at all paying its short term obligations.
  • DVAX has a Current ratio of 7.62. This is in the better half of the industry: DVAX outperforms 72.99% of its industry peers.
  • DVAX has a Quick Ratio of 6.94. This indicates that DVAX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of DVAX (6.94) is better than 69.92% of its industry peers.
Industry RankSector Rank
Current Ratio 7.62
Quick Ratio 6.94
DVAX Yearly Current Assets VS Current LiabilitesDVAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. DVAX Growth Analysis

3.1 Past

  • DVAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 211.54%, which is quite impressive.
  • The earnings per share for DVAX have been decreasing by -19.10% on average. This is quite bad
  • Looking at the last year, DVAX shows a very strong growth in Revenue. The Revenue has grown by 26.73%.
  • The Revenue has been growing by 51.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)211.54%
EPS 3Y-19.1%
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)26.73%
Revenue growth 3Y-14.23%
Revenue growth 5Y51.1%
Sales Q2Q%17.67%

3.2 Future

  • Based on estimates for the next years, DVAX will show a very strong growth in Earnings Per Share. The EPS will grow by 63.12% on average per year.
  • The Revenue is expected to grow by 15.42% on average over the next years. This is quite good.
EPS Next Y-318.17%
EPS Next 2Y72.81%
EPS Next 3Y63.12%
EPS Next 5YN/A
Revenue Next Year21.89%
Revenue Next 2Y18.83%
Revenue Next 3Y17.54%
Revenue Next 5Y15.42%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DVAX Yearly Revenue VS EstimatesDVAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
DVAX Yearly EPS VS EstimatesDVAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

5

4. DVAX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 37.80, the valuation of DVAX can be described as expensive.
  • Based on the Price/Earnings ratio, DVAX is valued cheaply inside the industry as 91.95% of the companies are valued more expensively.
  • DVAX is valuated expensively when we compare the Price/Earnings ratio to 24.89, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 28.84, DVAX can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DVAX indicates a rather cheap valuation: DVAX is cheaper than 91.76% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. DVAX is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 37.8
Fwd PE 28.84
DVAX Price Earnings VS Forward Price EarningsDVAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 90.61% of the companies in the same industry are more expensive than DVAX, based on the Enterprise Value to EBITDA ratio.
  • DVAX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DVAX is cheaper than 95.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.88
EV/EBITDA 66.27
DVAX Per share dataDVAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • DVAX has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as DVAX's earnings are expected to grow with 63.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.81%
EPS Next 3Y63.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DVAX Dividend Analysis

5.1 Amount

  • No dividends for DVAX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DVAX Fundamentals: All Metrics, Ratios and Statistics

DYNAVAX TECHNOLOGIES CORP

NASDAQ:DVAX (2/9/2026, 8:00:01 PM)

After market: 15.5 0 (0%)

15.5

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)02-18
Inst Owners98.72%
Inst Owner Change-0.32%
Ins Owners0.71%
Ins Owner Change-2122.58%
Market Cap1.76B
Revenue(TTM)330.51M
Net Income(TTM)-43.40M
Analysts80
Price Target20.91 (34.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.4%
Min EPS beat(2)30.1%
Max EPS beat(2)64.71%
EPS beat(4)3
Avg EPS beat(4)6.21%
Min EPS beat(4)-86.66%
Max EPS beat(4)64.71%
EPS beat(8)6
Avg EPS beat(8)-6.9%
EPS beat(12)9
Avg EPS beat(12)66.09%
EPS beat(16)11
Avg EPS beat(16)67.73%
Revenue beat(2)1
Avg Revenue beat(2)3.46%
Min Revenue beat(2)-1.05%
Max Revenue beat(2)7.97%
Revenue beat(4)1
Avg Revenue beat(4)-0.31%
Min Revenue beat(4)-4.19%
Max Revenue beat(4)7.97%
Revenue beat(8)2
Avg Revenue beat(8)-2.29%
Revenue beat(12)6
Avg Revenue beat(12)3.06%
Revenue beat(16)8
Avg Revenue beat(16)4.4%
PT rev (1m)-1.2%
PT rev (3m)-14.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-45%
EPS NY rev (1m)0%
EPS NY rev (3m)12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 37.8
Fwd PE 28.84
P/S 5.33
P/FCF 21.88
P/OCF 19.44
P/B 3.3
P/tB 3.31
EV/EBITDA 66.27
EPS(TTM)0.41
EY2.65%
EPS(NY)0.54
Fwd EY3.47%
FCF(TTM)0.71
FCFY4.57%
OCF(TTM)0.8
OCFY5.14%
SpS2.91
BVpS4.7
TBVpS4.68
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.58
Profitability
Industry RankSector Rank
ROA -4.59%
ROE -8.13%
ROCE 1.24%
ROIC 1.05%
ROICexc 3.98%
ROICexgc 4.02%
OM 3.16%
PM (TTM) N/A
GM 83.17%
FCFM 24.37%
ROA(3y)10.61%
ROA(5y)3.5%
ROE(3y)17.99%
ROE(5y)-8.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-15.64%
PM growth 5YN/A
GM growth 3Y10.73%
GM growth 5Y12.85%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.24
Debt/EBITDA 20.41
Cap/Depr 429.21%
Cap/Sales 3.05%
Interest Coverage 2.16
Cash Conversion 708.62%
Profit Quality N/A
Current Ratio 7.62
Quick Ratio 6.94
Altman-Z 2.44
F-Score5
WACC8.24%
ROIC/WACC0.13
Cap/Depr(3y)139.55%
Cap/Depr(5y)160.56%
Cap/Sales(3y)1.68%
Cap/Sales(5y)6.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)211.54%
EPS 3Y-19.1%
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y-318.17%
EPS Next 2Y72.81%
EPS Next 3Y63.12%
EPS Next 5YN/A
Revenue 1Y (TTM)26.73%
Revenue growth 3Y-14.23%
Revenue growth 5Y51.1%
Sales Q2Q%17.67%
Revenue Next Year21.89%
Revenue Next 2Y18.83%
Revenue Next 3Y17.54%
Revenue Next 5Y15.42%
EBIT growth 1Y240.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year458.87%
EBIT Next 3Y103.78%
EBIT Next 5YN/A
FCF growth 1Y-31.63%
FCF growth 3Y-43.07%
FCF growth 5YN/A
OCF growth 1Y-25.53%
OCF growth 3Y-41.69%
OCF growth 5YN/A

DYNAVAX TECHNOLOGIES CORP / DVAX Fundamental Analysis FAQ

What is the fundamental rating for DVAX stock?

ChartMill assigns a fundamental rating of 6 / 10 to DVAX.


Can you provide the valuation status for DYNAVAX TECHNOLOGIES CORP?

ChartMill assigns a valuation rating of 6 / 10 to DYNAVAX TECHNOLOGIES CORP (DVAX). This can be considered as Fairly Valued.


How profitable is DYNAVAX TECHNOLOGIES CORP (DVAX) stock?

DYNAVAX TECHNOLOGIES CORP (DVAX) has a profitability rating of 6 / 10.


Can you provide the financial health for DVAX stock?

The financial health rating of DYNAVAX TECHNOLOGIES CORP (DVAX) is 6 / 10.